We read with interest the article by Stepanova et al in a recent issue of Gut. These authors used death certificate data from the third National Health and Nutrition Examination survey (NHANES-III 1988e1994) in order to assess the impact of metabolic syndrome components on all-cause and cause-specific mortality in patients with chronic liver disease (CLD).To gain a better understanding of these unexpected findings, we believe that the authors should provide the number of deathsand the age-, and sex-standardised rates for all-cause and CVD mortality for the suspected NAFLD group and the control group.

Risk of all-cause and cardiovascular mortality in patients with chronic liver disease. [Letter]

TARGHER, Giovanni;ZOPPINI, Giacomo;
2011-01-01

Abstract

We read with interest the article by Stepanova et al in a recent issue of Gut. These authors used death certificate data from the third National Health and Nutrition Examination survey (NHANES-III 1988e1994) in order to assess the impact of metabolic syndrome components on all-cause and cause-specific mortality in patients with chronic liver disease (CLD).To gain a better understanding of these unexpected findings, we believe that the authors should provide the number of deathsand the age-, and sex-standardised rates for all-cause and CVD mortality for the suspected NAFLD group and the control group.
2011
NAFLD; cardiovascular disease; metabolic syndrome
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/346135
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact